The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply. Staad – Biosynth, a leading developer and supplier of critical raw materials and services for life sciences and diagnostics, is pleased to announce the opening of its expanded GMP bioconjugation […]
The life science group Sartorius has successfully closed the acquisition of MatTek Corp, including Visikol Inc, from the Swedish BICO Group AB, as announced in April. The acquisition was completed on July 1, 2025, following the receipt of the required regulatory approval and the fulfillment of other customary closing conditions. With the integration of the […]
Ann Arbor, MI — There is a growing demand from medical research institutions for high resolution, compact imaging tools to better study disease progression in areas such as cancer, cardiovascular and neurodegenerative diseases and to develop novel treatments including radiotherapies. The first systems from MH3D, US-based innovator in compact pre-clinical single photon emission computed tomography […]
ICO has as of today completed the divestment of MatTek and Visikol to Sartorius, for USD 80m on a cash and debt-free basis, after customary regulatory approval has been obtained. Following transaction costs, net debt and working capital adjustments net proceeds are estimated to amount to USD 77.2m. The divestment follows the Group’s updated strategy […]
Saint-Germain-en-Laye, France – Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and bioanalytical products. Under this agreement, Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the United Kingdom. MN’s Bioanalysis […]
Enabling Scalable, Non-Viral Cell Engineering for Research, Biomanufacturing, and Therapeutic Development — TOKYO — The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as “PHCbi”), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo, hereafter referred to as “PHCHD”) announces it has signed an exclusive agreement with MaxCyte, Inc. […]
Funding to accelerate platform expansion into new applications in cell-to-cell interactions and tissue STOCKHOLM, Sweden — Pixelgen Technologies today announced that it has been awarded grant and equity financing of EUR 12.5 M ($14.7 million) from the European Innovation Council (EIC) Accelerator, a funding initiative under the European Union’s Horizon Europe program designed to support highly innovative start-ups with […]
Combined market-leading speed and 27 channel capacity enable maximum flexibility and data generation New fluidics and clog detection systems further simplify operation and reduce instrument downtime Intuitive software supports 24 hours of continuous runtime and easy analysis of complex high-throughput datasets Göttingen, Germany — The life science group Sartorius launches the new iQue® 5 High-Throughput […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher’s digital transformation and its ambition to lead the […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025. Mr. Milosevich has served as Vice President and Group Executive of the […]
Pay Invoice
Latest Blogs
-
Syncell: Advancing Spatial Proteomics
June 30, 2025 3:41 pm
-
SDi Forecasts Growth in Demand for Analytical Instruments 2024–2029
May 29, 2025 1:38 pm
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
